• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Safety of influenza vaccination on adverse birth outcomes among pregnant women: a prospective cohort study in Japan

tetano

Editor, Senior Moderator
Int J Infect Dis. 2020 Jan 23. pii: S1201-9712(20)30035-7. doi: 10.1016/j.ijid.2020.01.033. [Epub ahead of print] [h=1]Safety of influenza vaccination on adverse birth outcomes among pregnant women: a prospective cohort study in Japan.[/h]
Ohfuji S[SUP]1[/SUP], Deguchi M[SUP]2[/SUP], Tachibana D[SUP]3[/SUP], Koyama M[SUP]3[/SUP], Takagi T[SUP]4[/SUP], Yoshioka T[SUP]5[/SUP], Urae A[SUP]6[/SUP], Ito K[SUP]7[/SUP], Kase T[SUP]8[/SUP], Maeda A[SUP]9[/SUP], Kondo K[SUP]10[/SUP], Fukushima W[SUP]8[/SUP], Hirota Y[SUP]11[/SUP]; Osaka Pregnant Women Influenza Study Group.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Pregnant women are placed on the highest priority group for receiving influenza vaccination, but may be reluctant to receive the vaccination due to concerns about the influence of vaccination on the fetuses.
[h=4]METHODS:[/h] This prospective cohort study of 10,330 pregnant women examined the safety of influenza vaccination in terms of adverse birth outcomes. Influenza vaccination during pregnancy was determined from questionnaires before and after the 2013/2014 influenza season. All subjects were followed until the end of pregnancy. Adverse birth outcomes, including miscarriage, stillbirth, preterm birth, low birth weight, and malformation, was assessed by obstetrician's reports.
[h=4]RESULTS:[/h] Adverse birth outcomes were reported from 641 (10%) among 6,387 unvaccinated pregnant women and 356 (9%) among 3,943 vaccinated pregnant women. Even after adjusting for potential confounders, vaccination during pregnancy showed no association with the risk of adverse birth outcomes (OR = 0.90, 95%CI = 0.76-1.07). Vaccination during the first or second trimester displayed no association with adverse birth outcomes, whereas vaccination during the third trimester was associated with decreased risk of adverse birth outcomes (OR = 0.70, 95%CI = 0.51-0.98).
[h=4]CONCLUSIONS:[/h] Influenza vaccination during pregnancy did not increase the risk of adverse birth outcomes, regardless of the trimester in which vaccination was performed, compared to unvaccinated pregnant women.
Copyright ? 2020. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] Adverse birth outcomes; Influenza vaccine; Pregnant women; Prospective cohort study; Vaccine safety

PMID: 31982621 DOI: 10.1016/j.ijid.2020.01.033
Free full text
 
Back
Top Bottom